Siegfried Holding AG, founded in 1873 and headquartered in Zofingen, Switzerland, specializes in the development and manufacturing of pharmaceutical products and intermediates. The company caters to a global clientele, offering services such as contract manufacturing, development, and commercialization of active pharmaceutical ingredients (APIs).
| Bond Name | Country | Maturity | Coupon(%) | |
|---|---|---|---|---|
| SFZZSW 0.20% 2026-06-15 CHFSiegfried Holding AG | Switzerland | 2026-06-15 | 0.200 | 0.65 |
Company overview and issue history are AI generated, and should not be cited or relied on without verification.
Siegfried began issuing bonds in 2015, demonstrating its commitment to enhancing financial flexibility and supporting growth initiatives. Notable issuances include a CHF 150 million bond in 2020, which was intended for general corporate purposes and reflected a competitive yield of approximately 1.75%, positioning it favorably among peers in the healthcare sector. In 2023, Siegfried also issued a green bond, further emphasizing its sustainability commitment, setting it apart from other issuers in the market.